Cite
HARVARD Citation
D'Haens, G. et al. (n.d.). P544 Patients with moderate to severe Crohn's disease with and without prior biologic failure demonstrated improved clinical outcomes with risankizumab: Results from phase 3 induction and maintenance trials. Journal of Crohn's and colitis. p. i491. [Online].